Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016

[1]  R. Pai,et al.  Colorectal carcinomas with submucosal invasion (pT1): analysis of histopathological and molecular factors predicting lymph node metastasis , 2017, Modern Pathology.

[2]  D. Lambrechts,et al.  Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching , 2016, British Journal of Cancer.

[3]  A. Rogers,et al.  Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer , 2016, British Journal of Cancer.

[4]  S. Kudo,et al.  Management of T1 colorectal cancers after endoscopic treatment based on the risk stratification of lymph node metastasis , 2016, Journal of gastroenterology and hepatology.

[5]  Y. Ajioka,et al.  Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer , 2016, Diseases of the colon and rectum.

[6]  Shigehisa Aoki,et al.  Cytokeratin immunohistochemistry improves interobserver variability between unskilled pathologists in the evaluation of tumor budding in T1 colorectal cancer , 2016, Pathology international.

[7]  M. Pollheimer,et al.  Tumour budding with and without admixed inflammation: two different sides of the same coin? , 2016, British Journal of Cancer.

[8]  Inti Zlobec,et al.  Tumor budding in colorectal cancer--ready for diagnostic practice? , 2016, Human pathology.

[9]  J. Cerhan,et al.  Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort , 2015, The American journal of surgical pathology.

[10]  Tetsuo Nemoto,et al.  A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study , 2015, Modern Pathology.

[11]  S. Barni,et al.  Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis , 2015, Journal of Gastrointestinal Cancer.

[12]  D. Chang,et al.  Meta-analysis of Predictive Clinicopathologic Factors for Lymph Node Metastasis in Patients with Early Colorectal Carcinoma , 2015, Journal of Korean medical science.

[13]  Masahiro Yoshida,et al.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer , 2011, International Journal of Clinical Oncology.

[14]  Y. Miyagi,et al.  Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer , 2015, Journal of Gastroenterology.

[15]  F. Offner,et al.  Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study , 2015, Virchows Archiv.

[16]  D. McMillan,et al.  The role of tumour budding in predicting survival in patients with primary operable colorectal cancer: a systematic review. , 2015, Cancer treatment reviews.

[17]  X. Sagaert,et al.  Tumour budding in colorectal cancer: what do we know and what can we do? , 2015, Virchows Archiv.

[18]  P. Bedossa,et al.  Pathological prognostic factors in locally advanced rectal carcinoma after neoadjuvant radiochemotherapy: analysis of 113 cases , 2014, Histopathology.

[19]  Y. Hirose,et al.  Predictors of Lymph Node Metastasis in T1 Colorectal Carcinoma: An Immunophenotypic Analysis of 265 Patients , 2014, Diseases of the colon and rectum.

[20]  S. Mondello,et al.  Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer , 2014, Virchows Archiv.

[21]  Long-bin Xiao,et al.  Tumour budding is a reproducible index for risk stratification of patients with Stage II colon cancer , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[22]  I. Zlobec,et al.  The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome , 2014, Histopathology.

[23]  M. Borner,et al.  Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients , 2013, British Journal of Cancer.

[24]  T. Fujimori,et al.  [The brand new trend of colorectal carcinoma pathology]. , 2014, Nihon rinsho. Japanese journal of clinical medicine.

[25]  Karin Haustermans,et al.  EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. , 2014, European journal of cancer.

[26]  A. Rogers,et al.  Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy , 2014, Modern Pathology.

[27]  Kenichi Sugihara,et al.  Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review , 2014, Journal of Gastroenterology.

[28]  I. Nagtegaal,et al.  EURECCA consensus conference highlights about colorectal cancer clinical management: the pathologists expert review , 2014, Virchows Archiv.

[29]  J. Borrás,et al.  EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. , 2013, European journal of cancer.

[30]  I. Nagtegaal,et al.  Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions , 2013, Endoscopy.

[31]  A. Radcliffe,et al.  Systematic review and meta‐analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[32]  L. Terracciano,et al.  Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. , 2013, Human pathology.

[33]  R. Soetikno,et al.  Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: a systematic review and meta-analysis , 2013, Surgical Endoscopy.

[34]  E. Patsouris,et al.  Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer , 2013, Modern Pathology.

[35]  H. Schünemann,et al.  [GRADE guidelines: 9. Rating up the quality of evidence]. , 2013, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[36]  D. Kerr,et al.  Stage II colon cancer. , 2013, Chinese clinical oncology.

[37]  S. Kaleci,et al.  Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature , 2014, Internal and Emergency Medicine.

[38]  Takatoshi Nakamura,et al.  Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy , 2012, Histopathology.

[39]  R. Riddell,et al.  Tumor budding in colorectal carcinoma: time to take notice , 2012, Modern Pathology.

[40]  Diarmuid P. O'Donoghue,et al.  Stage II colonic adenocarcinoma: a detailed study of pT4N0 with emphasis on peritoneal involvement and the role of tumour budding , 2012, Histopathology.

[41]  M. Borner,et al.  Role of Intra- and Peritumoral Budding in the Interdisciplinary Management of Rectal Cancer Patients , 2012, International journal of surgical oncology.

[42]  J. Gu,et al.  Morphology and prognostic value of tumor budding in rectal cancer after neoadjuvant radiotherapy. , 2012, Human pathology.

[43]  M. Kurrer,et al.  Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer , 2012, Modern Pathology.

[44]  M. Pollheimer,et al.  Tumor Budding is an Independent Predictor of Outcome in AJCC/UICC Stage II Colorectal Cancer , 2012, Annals of Surgical Oncology.

[45]  K. Chayama,et al.  Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection , 2012, Journal of gastroenterology and hepatology.

[46]  M. Kim,et al.  Predictors for lymph node metastasis in T1 colorectal cancer , 2012, Endoscopy.

[47]  I. Zlobec,et al.  Tumour budding: a promising parameter in colorectal cancer , 2012, British Journal of Cancer.

[48]  H. Ueno,et al.  New Criteria for Histologic Grading of Colorectal Cancer , 2012, The American journal of surgical pathology.

[49]  J. Kim,et al.  Clinicopathologic Factors Affecting Recurrence after Curative Surgery for Stage I Colorectal Cancer , 2012, Journal of the Korean society of coloproctology.

[50]  Lawrence J. Burgart,et al.  Meta-analysis of Histopathological Features of Primary Colorectal Cancers that Predict Lymph Node Metastases , 2012, Journal of Gastrointestinal Surgery.

[51]  H. Schünemann,et al.  [GRADE guidelines: 2. Framing the question and deciding on important outcomes]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[52]  Gerald Gartlehner,et al.  [GRADE guidelines: 8. Rating the quality of evidence - indirectness]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[53]  Gerald Gartlehner,et al.  [GRADE guidelines: 7. Rating the quality of evidence - inconsistency]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[54]  Gerald Gartlehner,et al.  [GRADE guidelines: 5. Rating the quality of evidence: publication bias]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[55]  Gerald Gartlehner,et al.  [GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[56]  T. Smyrk,et al.  Partial Pathologic Response and Nodal Status as Most Significant Prognostic Factors for Advanced Rectal Cancer Treated With Preoperative Chemoradiotherapy , 2012, World Journal of Surgery.

[57]  L. Terracciano,et al.  Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients. , 2011, Human pathology.

[58]  G. Guyatt,et al.  GRADE guidelines 6. Rating the quality of evidence--imprecision. , 2011, Journal of clinical epidemiology.

[59]  G. Guyatt,et al.  GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). , 2011, Journal of clinical epidemiology.

[60]  G. Guyatt,et al.  GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. , 2011, Journal of clinical epidemiology.

[61]  F. Piscioli,et al.  Accurate and reproducible definition of tumor budding as prognostic marker of colon cancer. , 2010, Diseases of the colon and rectum.

[62]  I. Zlobec,et al.  Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget , 2010, Oncotarget.

[63]  Colin C Pritchard,et al.  Colorectal cancer molecular biology moves into clinical practice , 2010, Gut.

[64]  H. Ueno,et al.  Risk Factors of Nodal Involvement in T2 Colorectal Cancer , 2010, Diseases of the colon and rectum.

[65]  H. Ueno,et al.  Proposed objective criteria for "grade 3" in early invasive colorectal cancer. , 2010, American journal of clinical pathology.

[66]  L. Terracciano,et al.  Systematic assessment of protein phenotypes characterizing high‐grade tumour budding in mismatch repair‐proficient colorectal cancer , 2010, Histopathology.

[67]  Tadakazu Shimoda,et al.  Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma , 2010, Modern Pathology.

[68]  K. Sheahan,et al.  Reproducibility of the rapid bud count method for assessment of tumor budding in stage II colorectal cancer. , 2010, The American journal of surgical pathology.

[69]  L. Terracciano,et al.  ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients. , 2010, World journal of gastroenterology.

[70]  L. Terracciano,et al.  ABCG 5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients , 2010 .

[71]  J. O’Sullivan,et al.  Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer , 2009, The American journal of surgical pathology.

[72]  A. Nonomura,et al.  Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma. , 2008, Anticancer research.

[73]  H. Mitomi,et al.  Tumor Budding as an Index to Identify High-Risk Patients with Stage II Colon Cancer , 2008, Diseases of the colon and rectum.

[74]  K. Chayama,et al.  Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer. , 2007, World journal of gastroenterology.

[75]  L. Terracciano,et al.  Role of APAF‐1, E‐cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancer , 2007, The Journal of pathology.

[76]  Comments on the reporting of lymph nodes and tumour budding in the checklist of colorectal carcinoma , 2007, Virchows Archiv.

[77]  F. Prall.  Tumour budding in colorectal carcinoma , 2007, Histopathology.

[78]  C. Ostwald,et al.  p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding. , 2006, Human pathology.

[79]  H. Ueno,et al.  A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo‐fragments around budding foci , 2005, Histopathology.

[80]  M. Barten,et al.  Tumour budding as prognostic factor in stage I/II colorectal carcinoma , 2005, Histopathology.

[81]  Shung-Haur Yang,et al.  Curative Resection of T1 Colorectal Carcinoma: Risk of Lymph Node Metastasis and Long-Term Prognosis , 2005, Diseases of the colon and rectum.

[82]  H. Nagawa,et al.  Pathological changes of advanced lower-rectal cancer by preoperative radiotherapy. , 2004, Hepato-gastroenterology.

[83]  Hidetaka Mochizuki,et al.  Risk factors for an adverse outcome in early invasive colorectal carcinoma. , 2004, Gastroenterology.

[84]  Toshihide Kumamoto,et al.  Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study , 2004, Journal of Gastroenterology.

[85]  Tetsuro Nakamura,et al.  Budding Is Useful to Select High-Risk Patients in Stage II Well-Differentiated or Moderately Differentiated Colon Adenocarcinoma , 2003, Diseases of the colon and rectum.

[86]  M. Oya,et al.  Budding as a useful prognostic marker in pT3 well‐ or moderately‐differentiated rectal adenocarcinoma , 2003, Journal of surgical oncology.

[87]  B. Leggett,et al.  APC mutation and tumour budding in colorectal cancer , 2003, Journal of clinical pathology.

[88]  M. Yamaguchi,et al.  Budding (sprouting) as a useful prognostic marker in colorectal mucinous carcinoma. , 2002, Japanese journal of clinical oncology.

[89]  H. Ueno,et al.  Tumour `budding' as an index to estimate the potential of aggressiveness in rectal cancer , 2002, Histopathology.

[90]  K. Hase,et al.  Prognostic value of tumor “budding” in patients with colorectal cancer , 1993, Diseases of the colon and rectum.

[91]  M. Morimatsu,et al.  An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer , 1989, Cancer.